Peptron, Inc. (KOSDAQ:087010)

Market Cap	6.13T
Revenue (ttm)	5.18B
Net Income (ttm)	-16.93B
Shares Out	23.32M
EPS (ttm)	-766.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	122,625
Average Volume	155,875
Open	259,500
Previous Close	265,000
Day's Range	255,500 - 267,000
52-Week Range	73,700 - 359,000
Beta	0.76
RSI	42.81
Earnings Date	n/a

About Peptron

Peptron, Inc. engages in the development of peptide-based medicines. The company’s technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. It develops PAb 001 for cancer therapy; SR-Exenatide (PT320) for Parkinson’s and other neurodegenerative disease; SR-Octreotide for the treatment of acromegaly; and Dernak filler for bioequivalence. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1997
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 087010

Financial Performance

In 2024, Peptron's revenue was 3.15 billion, a decrease of -5.68% compared to the previous year's 3.34 billion. Losses were -22.03 billion, 38.4% more than in 2023.